Jose Luis Vázquez-Barquero, MD, PhD

Jose Luis Vázquez-Barquero, MD, PhD, has contributed to Psychiatrist.com between 2006 and 2007, authoring three articles primarily focused on neurology. Frequent collaborators include Benedicto Crespo-Facorro, Obdulia Martínez-García, Rocío Pérez-Iglesias, Cesar González-Blanch, and Javier LLorca.

Neurology

Frequent co-authors

Benedicto Crespo-Facorro Obdulia Martínez-García Rocío Pérez-Iglesias Cesar González-Blanch Javier LLorca Jose Antonio Amado Mari Luz Ramírez-Bonilla Maria Luz Ramirez-Bonilla

Original Research

A 12-Week Randomized Clinical Trial to Evaluate Metabolic Changes in Drug-Naive, First-Episode Psychosis Patients Treated With Haloperidol, Olanzapine, or Risperidone

November 15, 2007

Cesar González-Blanch, Jose Luis Vázquez-Barquero, Rocío Pérez-Iglesias, et al

Original Research

A Practical Clinical Trial Comparing Haloperidol, Risperidone, and Olanzapine for the Acute Treatment of First-Episode Nonaffective Psychosis.

October 16, 2006

Jose Luis Vázquez-Barquero, Rocío Pérez-Iglesias, Obdulia Martínez-García, et al

Original Research

Attenuation of Antipsychotic-Induced Weight Gain With Early Behavioral Intervention in Drug-Naive First-Episode Psychosis Patients: A Randomized Controlled Trial

August 15, 2006

Mario Álvarez-Jiménez, Cesar González-Blanch, Jose Luis Vázquez-Barquero, et al

Jose Luis Vázquez-Barquero, MD, PhD

Frequent co-authors

A 12-Week Randomized Clinical Trial to Evaluate Metabolic Changes in Drug-Naive, First-Episode Psychosis Patients Treated With Haloperidol, Olanzapine, or Risperidone

A Practical Clinical Trial Comparing Haloperidol, Risperidone, and Olanzapine for the Acute Treatment of First-Episode Nonaffective Psychosis.

Attenuation of Antipsychotic-Induced Weight Gain With Early Behavioral Intervention in Drug-Naive First-Episode Psychosis Patients: A Randomized Controlled Trial

ELSEWHERE:

FOLLOW US:

Jose Luis Vázquez-Barquero, MD, PhD

Frequent co-authors

A 12-Week Randomized Clinical Trial to Evaluate Metabolic Changes in Drug-Naive, First-Episode Psychosis Patients Treated With Haloperidol, Olanzapine, or Risperidone

A Practical Clinical Trial Comparing Haloperidol, Risperidone, and Olanzapine for the Acute Treatment of First-Episode Nonaffective Psychosis.

Attenuation of Antipsychotic-Induced Weight Gain With Early Behavioral Intervention in Drug-Naive First-Episode Psychosis Patients: A Randomized Controlled Trial

Live Webinar and Q&A With Dr Deligiannidis

Subscribe to readmore articles

Live Webinar
and Q&A With
Dr Deligiannidis

Subscribe to read
more articles